Observational Study of Patients Undergoing Diagnostic Right Heart Catheterization
Purpose
The objective of this observational pilot study is to collect HemoCept device data from subjects undergoing diagnostic right heart catheterization (RHC) procedures.
Conditions
- Pulmonary Hypertension
- Congestive Heart Failure(CHF)
- Valve Disease, Heart
Eligibility
- Eligible Ages
- Over 18 Years
- Eligible Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- Subjects or representatives must have voluntarily signed the informed consent form before any study related procedures. - Subjects can be any gender but must be age 18 or older. - Subject is able and willing to provide informed consent and HIPAA authorization. - Subject is able and willing to meet all study requirements. - Scheduled for a diagnostic right heart catheterization (RHC-only or combined RHC+LHC; left-heart-only procedures are not eligible)
Exclusion Criteria
- Subject is pregnant, breastfeeding, or intends to become pregnant during this study.
Study Design
- Phase
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Prospective
Recruiting Locations
Boulder Heart
Boulder 5574991, Colorado 5417618 80303
Boulder 5574991, Colorado 5417618 80303
More Details
- Status
- Recruiting
- Sponsor
- HemoCept Inc.